Decision on amending the marketing authorisation granted by Decision C(2022) 7342(final) for “Comirnaty - tozinameran, COVID-19 mRNA vaccine (nucleoside-modified)”, a medicinal product for human use
COMCMT1R-EP1R-C2R-EPCNCADO
Activity
Political balance
GovLens uses a simple verification process to ensure every citizen gets exactly one voice. Your identity is never linked to your positions.
Create an accountSome data sources haven't been updated in over 48 hours.
